Pentavac, Poudre et suspension pour suspension injectable - Durchstechflasche(n) Swissmedic Key 00613001 Registration Holder Sanofi-Aventis (Suisse) SA Name Pentavac, Poudre et suspension pour suspension injectable Date of registration 18.08.1999 Introduction of Sequence 18.08.1999 ATC-Classification Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus (J07CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.08. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 08.08. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 34.19 Limitation Yes Limitation text
Deductible 10 % Consumer price 53.60 Feedback FB GTIN 7680006130012 Medication Code Impfstoffe Pharmacode Disponibility
Composition I) composant DPTa-IPV (suspension): toxoidum diphtheriae min. 20 U.I., toxoidum tetani min. 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, phenoxyethanolum, ethanolum anhydricum 2 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: neomycinum, streptomycinum, polymyxinum B nihil.
II) composant Hib (poudre): polysaccharida haemophili influenzae typus B 1482 conjugata cum toxoido tetani 10 µg, trometamolum, saccharum, acidum hydrochloridum q.s. ad pH, pro praeparatione. Packungsbestandteile Label II
Galenic Form suspension injectable et lyophilisat Excipiens BAG: Active Agent Dose Haemagglutinium Filamentosum (B. Pertussis) 25 mcg Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg Toxoidum Diphtheriae 20 UI Toxoidum Pertussis 25 mcg Toxoidum Tetani 40 UI Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 U Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 U Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 U
Inactive agents Dose Acidum Hydrochloridum Composant hib (Poudre): Polysaccharida Haemophili Influenzae Typus B 1482 Conjugata cum Toxoido Tetani 10 µg Saccharum Trometamol
Label I
Galenic Form Poudre et suspension pour suspension injectable Excipiens Active Agent Dose Composant Dpta-Ipv (Suspension): Toxoidum Diphtheriae 20 UI Toxoidum Tetani 40 UI
BAG: Active Agent Dose Haemagglutinium Filamentosum (B. Pertussis) 25 mcg Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg Toxoidum Diphtheriae 20 UI Toxoidum Pertussis 25 mcg Toxoidum Tetani 40 UI Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 U Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 U Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 U
Inactive agents Dose additional_information Acidum Aceticum Glaciale Alumine 0.3 mg Cum Phenylalaninum 12.5 µg Formaldehydum Haemagglutininum Filamentosum 25 µg Inactivatus 26 U Potassium Medium 199 Toxoidum Pertussis 25 µg bordetellae pertussis antigenum Virus Poliomyelitis Typus 3
Source Data was imported : 04.04.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
